0

Your Cart is Empty

Dr Kent Holtorf – Longevity & LDN

Dr Kent Holtorf's amazing webinar presentations on Longevity.

You can to watch the 2+ hour Recording with Live Q&A's and download the comprehensive PowerPoint, there is so much to learn.

Kent Holtorf, MD, is the medical director of the Holtorf Medical Group(Holtorfmed.com) and founder and medical director of the non-profit National Academy of Hypothyroidism (NAHypothyroidism.org). He is also the founder of Integrative Peptides (IntegrativePeptides.com), dedicated to training physicians about ground-breaking peptide therapies and bringing doctors and patients the highest quality natural bioidentical peptides as supplements with unique delivery systems.

Dr Holtorf is an internationally known lecturer, author, and innovator in cutting-edge research and treatments. He has personally trained numerous physicians across the country in the use of bioidentical hormones, thyroid replacement for complex hypothyroidism syndromes, peptide therapies, immune-modulatory strategies, stem cell, exosome and growth factor treatment, hormone replacement for complex endocrine dysfunction, and innovative treatments of chronic fatigue syndrome, fibromyalgia, Lyme disease, and other chronic infectious diseases, CIRS, neurodegenerative diseases, and many others.

He is a fellowship lecturer for A4M. He was the Endocrinology Expert for AOL Health and is a guest editor and peer-reviewer for the medical journals Endocrine, Postgraduate Medicine, and Pharmacy Practice. Dr Holtorf has published many peer-reviewed endocrine reviews on complex, multisystem, poorly understood conditions.

He has demonstrated that much of the long-held dogma in endocrinology and infectious disease is inaccurate.

He has been a featured guest on CNBC, ABC News, CNN, Fox News (debated the Fox news medical A-team), Good Morning America, The Today Show, EXTRA TV, Discovery Health, The Learning Channel, Glenn Beck, Nancy Grace, Sean Hannity, and more and quoted in numerous print media including the Wall Street Journal, Los Angeles Times, US News and World Report, San Francisco Chronicle, WebMD, Forbes, among many others.